Megan Boston - 06 Mar 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Executive Director, Director
Signature
/s/ Megan Boston
Issuer symbol
BNTC
Transactions as of
06 Mar 2024
Net transactions value
$0
Form type
4
Filing time
08 Mar 2024, 16:12:19 UTC
Previous filing
14 Aug 2023
Next filing
11 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +200,004 $0.000000 200,004 06 Mar 2024 Common Stock 200,004 $5.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.